Cargando…

Evaluation of a Low-Dose Computed Tomography Lung Cancer Screening Program in Henan, China

IMPORTANCE: Lung cancer screening has been widely implemented in Europe and the US. However, there is little evidence on participation and diagnostic yields in population-based lung cancer screening in China. OBJECTIVE: To assess the participation rate and detection rate of lung cancer in a populati...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Lan-Wei, Chen, Qiong, Shen, Yin-Chen, Meng, Qing-Cheng, Zheng, Li-Yang, Wu, Yue, Cao, Xiao-Qin, Xu, Hui-Fang, Liu, Shu-Zheng, Sun, Xi-Bin, Qiao, You-Lin, Zhang, Shao-Kai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610188/
https://www.ncbi.nlm.nih.gov/pubmed/33141158
http://dx.doi.org/10.1001/jamanetworkopen.2020.19039
_version_ 1783605151904301056
author Guo, Lan-Wei
Chen, Qiong
Shen, Yin-Chen
Meng, Qing-Cheng
Zheng, Li-Yang
Wu, Yue
Cao, Xiao-Qin
Xu, Hui-Fang
Liu, Shu-Zheng
Sun, Xi-Bin
Qiao, You-Lin
Zhang, Shao-Kai
author_facet Guo, Lan-Wei
Chen, Qiong
Shen, Yin-Chen
Meng, Qing-Cheng
Zheng, Li-Yang
Wu, Yue
Cao, Xiao-Qin
Xu, Hui-Fang
Liu, Shu-Zheng
Sun, Xi-Bin
Qiao, You-Lin
Zhang, Shao-Kai
author_sort Guo, Lan-Wei
collection PubMed
description IMPORTANCE: Lung cancer screening has been widely implemented in Europe and the US. However, there is little evidence on participation and diagnostic yields in population-based lung cancer screening in China. OBJECTIVE: To assess the participation rate and detection rate of lung cancer in a population-based screening program and the factors associated with participation. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used data from the Cancer Screening Program in Urban China from October 2013 to October 2019, with follow-up until March 10, 2020. The program is conducted at centers in 8 cities in Henan Province, China. Eligible participants were aged 40 to 74 and were evaluated for a high risk for lung cancer using an established risk score system. MAIN OUTCOMES AND MEASURES: Overall and group-specific participation rates by common factors, such as age, sex, and educational level, were calculated. Differences in participation rates between those groups were compared. The diagnostic yield of both screening and nonscreening groups was calculated. RESULTS: The study recruited 282 377 eligible participants and included 55 428 with high risk for lung cancer; the mean (SD) age was 55.3 (8.1) years, and 34 966 participants (63.1%) were men. A total of 22 260 participants underwent LDCT (participation rate, 40.16%; 95% CI, 39.82%-40.50%). The multivariable logistic regression model showed that female sex (odds ratio [OR], 1.64; 95% CI, 1.52-1.78), former smoking (OR, 1.26; 95% CI, 1.13-1.41), lack of physical activity (OR, 1.19; 95% CI, 1.14-1.24), family history of lung cancer (OR, 1.73; 95% CI, 1.66-1.79), and 7 other factors were associated with increased participation of LDCT screening. Overall, at 6-year follow-up, 78 participants in the screening group (0.35%; 95% CI, 0.29%-0.42%) and 125 in the nonscreening group (0.38%; 95% CI, 0.33%-0.44%) had lung cancer detected, which resulted in an odds ratio of 0.93 (95% CI, 0.70-1.23; P = .61). CONCLUSIONS AND RELEVANCE: The low participations rate in the program studied suggests that an improved strategy is needed. These findings may provide useful information for designing effective population-based lung cancer screening strategies in the future.
format Online
Article
Text
id pubmed-7610188
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-76101882020-11-10 Evaluation of a Low-Dose Computed Tomography Lung Cancer Screening Program in Henan, China Guo, Lan-Wei Chen, Qiong Shen, Yin-Chen Meng, Qing-Cheng Zheng, Li-Yang Wu, Yue Cao, Xiao-Qin Xu, Hui-Fang Liu, Shu-Zheng Sun, Xi-Bin Qiao, You-Lin Zhang, Shao-Kai JAMA Netw Open Original Investigation IMPORTANCE: Lung cancer screening has been widely implemented in Europe and the US. However, there is little evidence on participation and diagnostic yields in population-based lung cancer screening in China. OBJECTIVE: To assess the participation rate and detection rate of lung cancer in a population-based screening program and the factors associated with participation. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study used data from the Cancer Screening Program in Urban China from October 2013 to October 2019, with follow-up until March 10, 2020. The program is conducted at centers in 8 cities in Henan Province, China. Eligible participants were aged 40 to 74 and were evaluated for a high risk for lung cancer using an established risk score system. MAIN OUTCOMES AND MEASURES: Overall and group-specific participation rates by common factors, such as age, sex, and educational level, were calculated. Differences in participation rates between those groups were compared. The diagnostic yield of both screening and nonscreening groups was calculated. RESULTS: The study recruited 282 377 eligible participants and included 55 428 with high risk for lung cancer; the mean (SD) age was 55.3 (8.1) years, and 34 966 participants (63.1%) were men. A total of 22 260 participants underwent LDCT (participation rate, 40.16%; 95% CI, 39.82%-40.50%). The multivariable logistic regression model showed that female sex (odds ratio [OR], 1.64; 95% CI, 1.52-1.78), former smoking (OR, 1.26; 95% CI, 1.13-1.41), lack of physical activity (OR, 1.19; 95% CI, 1.14-1.24), family history of lung cancer (OR, 1.73; 95% CI, 1.66-1.79), and 7 other factors were associated with increased participation of LDCT screening. Overall, at 6-year follow-up, 78 participants in the screening group (0.35%; 95% CI, 0.29%-0.42%) and 125 in the nonscreening group (0.38%; 95% CI, 0.33%-0.44%) had lung cancer detected, which resulted in an odds ratio of 0.93 (95% CI, 0.70-1.23; P = .61). CONCLUSIONS AND RELEVANCE: The low participations rate in the program studied suggests that an improved strategy is needed. These findings may provide useful information for designing effective population-based lung cancer screening strategies in the future. American Medical Association 2020-11-03 /pmc/articles/PMC7610188/ /pubmed/33141158 http://dx.doi.org/10.1001/jamanetworkopen.2020.19039 Text en Copyright 2020 Guo L-W et al. JAMA Network Open. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Guo, Lan-Wei
Chen, Qiong
Shen, Yin-Chen
Meng, Qing-Cheng
Zheng, Li-Yang
Wu, Yue
Cao, Xiao-Qin
Xu, Hui-Fang
Liu, Shu-Zheng
Sun, Xi-Bin
Qiao, You-Lin
Zhang, Shao-Kai
Evaluation of a Low-Dose Computed Tomography Lung Cancer Screening Program in Henan, China
title Evaluation of a Low-Dose Computed Tomography Lung Cancer Screening Program in Henan, China
title_full Evaluation of a Low-Dose Computed Tomography Lung Cancer Screening Program in Henan, China
title_fullStr Evaluation of a Low-Dose Computed Tomography Lung Cancer Screening Program in Henan, China
title_full_unstemmed Evaluation of a Low-Dose Computed Tomography Lung Cancer Screening Program in Henan, China
title_short Evaluation of a Low-Dose Computed Tomography Lung Cancer Screening Program in Henan, China
title_sort evaluation of a low-dose computed tomography lung cancer screening program in henan, china
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7610188/
https://www.ncbi.nlm.nih.gov/pubmed/33141158
http://dx.doi.org/10.1001/jamanetworkopen.2020.19039
work_keys_str_mv AT guolanwei evaluationofalowdosecomputedtomographylungcancerscreeningprograminhenanchina
AT chenqiong evaluationofalowdosecomputedtomographylungcancerscreeningprograminhenanchina
AT shenyinchen evaluationofalowdosecomputedtomographylungcancerscreeningprograminhenanchina
AT mengqingcheng evaluationofalowdosecomputedtomographylungcancerscreeningprograminhenanchina
AT zhengliyang evaluationofalowdosecomputedtomographylungcancerscreeningprograminhenanchina
AT wuyue evaluationofalowdosecomputedtomographylungcancerscreeningprograminhenanchina
AT caoxiaoqin evaluationofalowdosecomputedtomographylungcancerscreeningprograminhenanchina
AT xuhuifang evaluationofalowdosecomputedtomographylungcancerscreeningprograminhenanchina
AT liushuzheng evaluationofalowdosecomputedtomographylungcancerscreeningprograminhenanchina
AT sunxibin evaluationofalowdosecomputedtomographylungcancerscreeningprograminhenanchina
AT qiaoyoulin evaluationofalowdosecomputedtomographylungcancerscreeningprograminhenanchina
AT zhangshaokai evaluationofalowdosecomputedtomographylungcancerscreeningprograminhenanchina